Angion down 17% after mid-stage acute kidney injury drug misses primary endpoint
10 December 2021 - 8:53AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Angion Biomedica (NASDAQ:ANGN)
Historical Stock Chart
From Apr 2023 to Apr 2024